Governments to Discuss Cali Fund at COP17 Summit
Delegates will address the voluntary fund for digital genetic sequence information from October 19 to 30, 2026.
Updated on Oct. 16, 2026 in Biotech
Live Poll
Should companies pay for using genetic data from nature to help fund global biodiversity protection?
Governments are set to debate the implementation of the Cali Fund at the COP17 biodiversity summit in Armenia, scheduled for October 19 to 30, 2026. The fund seeks to channel commercial value from Digital Sequence Information into global biodiversity protection.
Why it matters
The fund acts as a multilateral mechanism to share benefits derived from genetic resources, yet companies have been hesitant to contribute. Many firms avoid payments because they do not currently guarantee compliance with individual national access and benefit-sharing legislation.
The Cali Fund invites commercial users to contribute 1 percent of annual profits or 0.1 percent of revenues. While contributions currently total USD 6,000, projections suggest the fund could generate between USD 929 million and USD 3.6 billion annually.
The players
Convention on Biological Diversity
This is a 1992 international treaty dedicated to the conservation of biological diversity and the sustainable use of its components.
Covington & Burling
This is a global law firm that provides legal analysis on international regulatory frameworks, including genetic access legislation.
The details
Companies often sequence DNA and upload genetic information into online databases to facilitate research and development. To navigate this landscape, 65 countries have established national laws governing the access and benefit-sharing of these genetic resources.
Timeline
1992: The Convention on Biological Diversity treaty was established.
2014: The Nagoya Protocol on access and benefit-sharing was signed.
2022: Countries agreed to establish a new benefit-sharing system.
July 2026: Covington & Burling published an analysis on national laws.
October 19-30, 2026: The COP17 biodiversity summit takes place in Armenia.
The Tech Race
The Cali Fund extends the benefit-sharing requirements established under the Nagoya Protocol on access and benefit-sharing. It represents a shift from localized, country-specific compliance toward a multilateral mechanism for managing Digital Sequence Information.
The establishment of global standards for genetic data could eventually dictate how pharmaceutical and agricultural products are developed and priced. Companies facing clearer compliance pathways may pass costs or benefits of these standardized protocols on to consumers.
The takeaway
The success of the Cali Fund depends on balancing voluntary contributions with the regulatory certainty that businesses require. Stakeholders should monitor COP17 outcomes to see if global standards can resolve the current disconnect between international goals and national laws.
Further reading
For additional context on the evolution of genetic research policies, visit the Biotech section.
Source note: This article includes information reported by Eco-Business.
Live Poll
Should companies pay for using genetic data from nature to help fund global biodiversity protection?
